ATOS · Atossa Therapeutics, Inc. · Fails to Deliver
$1.65
-0.10 (-5.71%)
At close · Nov 20
Return incl. dividend (before tax)
Q2 2023 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Substantial doubt exists about our ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$15.92M
Shares
9.98M
Volume · Nov 20
48.93K
Avg daily vol (3M)
67.59K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-14 | 165 | $2.56 | $422 |
| 2026-10-13 | 31 | $2.39 | $74 |
| 2026-10-06 | 687 | $2.45 | $1,683 |
| 2026-10-05 | 1 | $2.34 | $2 |
| 2026-09-25 | 1,708 | $2.05 | $3,501 |
| 2026-09-21 | 652 | $2.22 | $1,447 |
| 2026-09-09 | 275 | $2.52 | $693 |
| 2026-08-31 | 12,270 | $2.58 | $31,657 |
| 2026-08-27 | 946 | $2.65 | $2,507 |
| 2026-08-25 | 4,359 | $2.64 | $11,508 |
Showing 1–10 of 10 settlements
Key facts
CIK
1488039
CUSIP
04962H704
13F (30d)
61 filings
35 filers
Visit website
Investor relations